- Home
- CNDT vs HUMA Comparison
CNDT vs HUMA Comparison
Compare CNDT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNDT
- HUMA
- Stock Information
- Founded
- CNDT 2016
- HUMA 2004
- Country
- CNDT United States
- HUMA United States
- Employees
- CNDT N/A
- HUMA N/A
- Industry
- CNDT Business Services
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- CNDT Consumer Discretionary
- HUMA Health Care
- Exchange
- CNDT Nasdaq
- HUMA Nasdaq
- Market Cap
- CNDT 441.8M
- HUMA 356.8M
- IPO Year
- CNDT N/A
- HUMA N/A
- Fundamental
- Price
- CNDT $2.48
- HUMA $2.48
- Analyst Decision
- CNDT
- HUMA Strong Buy
- Analyst Count
- CNDT 0
- HUMA 7
- Target Price
- CNDT N/A
- HUMA $13.00
- AVG Volume (30 Days)
- CNDT 908.7K
- HUMA 4.2M
- Earning Date
- CNDT 08-06-2025
- HUMA 08-11-2025
- Dividend Yield
- CNDT N/A
- HUMA N/A
- EPS Growth
- CNDT N/A
- HUMA N/A
- EPS
- CNDT 0.06
- HUMA N/A
- Revenue
- CNDT $3,112,000,000.00
- HUMA $517,000.00
- Revenue This Year
- CNDT N/A
- HUMA N/A
- Revenue Next Year
- CNDT $2.85
- HUMA $936.09
- P/E Ratio
- CNDT $40.01
- HUMA N/A
- Revenue Growth
- CNDT N/A
- HUMA N/A
- 52 Week Low
- CNDT $1.90
- HUMA $1.15
- 52 Week High
- CNDT $4.90
- HUMA $8.24
- Technical
- Relative Strength Index (RSI)
- CNDT 40.64
- HUMA 53.95
- Support Level
- CNDT $2.34
- HUMA $2.14
- Resistance Level
- CNDT $2.75
- HUMA $2.39
- Average True Range (ATR)
- CNDT 0.12
- HUMA 0.21
- MACD
- CNDT -0.03
- HUMA -0.01
- Stochastic Oscillator
- CNDT 27.45
- HUMA 48.57
About CNDT Conduent Incorporated
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.